APA

Jardim D. L., Wheler J. J., Hess K., Tsimberidou A. M., Zinner R., Janku F., Subbiah V., Naing A., Piha-Paul S. A., Westin S. N., Roy-Chowdhuri S., Meric-Bernstam F. & Hong D. S. (20141014). FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors. : PloS one.

Chicago

Jardim Denis L, Wheler Jennifer J, Hess Kenneth, Tsimberidou Apostolia M, Zinner Ralph, Janku Filip, Subbiah Vivek, Naing Aung, Piha-Paul Sarina A, Westin Shannon N, Roy-Chowdhuri Sinchita, Meric-Bernstam Funda and Hong David S. 20141014. FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors. : PloS one.

Harvard

Jardim D. L., Wheler J. J., Hess K., Tsimberidou A. M., Zinner R., Janku F., Subbiah V., Naing A., Piha-Paul S. A., Westin S. N., Roy-Chowdhuri S., Meric-Bernstam F. and Hong D. S. (20141014). FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors. : PloS one.

MLA

Jardim Denis L, Wheler Jennifer J, Hess Kenneth, Tsimberidou Apostolia M, Zinner Ralph, Janku Filip, Subbiah Vivek, Naing Aung, Piha-Paul Sarina A, Westin Shannon N, Roy-Chowdhuri Sinchita, Meric-Bernstam Funda and Hong David S. FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors. : PloS one. 20141014.